Amyris Inc 3A01-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 03/05/21 CET
13.40quote price arrow up+0.40 (+3.08%)
Volume
1,931
52 week range
1.25 - 18.04

...

Loading . . .

KEY STATS

  • Open13.52
  • Day High14.14
  • Day Low12.61
  • Prev Close13.40
  • 52 Week High18.04
  • 52 Week High Date03/02/21
  • 52 Week Low1.25
  • 52 Week Low Date03/16/20
  • Market Cap3,860.87M
  • Shares Out239.21M
  • 10 Day Average Volume61,936.82
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change297.63

RATIOS/PROFITABILITY

  • EPS (TTM)-1.52
  • P/E (TTM)-8.82
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Amyris Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Amyris, Inc. is an industrial biotechnology company. The Company is primarily focused on applying its technology platform to engineer, manufacture and sell high performance, natural, sustainably-sourced products into the Health & Wellness, Clean Beauty, and Flavor and Fragrance markets. Its technology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into volume, high-value ingredients. Its...
Geoffrey Duyk M.D. Ph.D.
Chairman
John Melo
Chief Executive Officer
Eduardo Alvarez
Chief Operating Officer
Han Kieftenbeld
Chief Financial Officer
Nicole Kelsey J.D.
General Counsel
Address
5885 Hollis St Ste 100
Emeryville, CA
94608-2405
United States